EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Neurofilament Light Chain and Cognitive Dysfunction in Patients Undergoing Hemodialysis

Kazuhiko Kato iD, Akio Nakashima iD, Shunichiro Shinagawa iD, Arisa Kobayashi, Ichiro Ohkido, Mitsuyoshi Urashima iD, Takashi Yokoo iD

Kidney360 · 2026

DOI: 10.34067/kid.0000001162 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kidney360, 2026. Verfasst von Kazuhiko Kato und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Renal Dialysis, Neurofilament Proteins, Cognitive Dysfunction, Kidney Failure, Chronic. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JSPS KAKENHI, The Grant for Pathophysiological Research Conference in Chronic Kidney Disease from The Kidney Foundation, Japan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cognitive dysfunction is frequently observed in patients undergoing hemodialysis in clinical settings; however, its pathophysiology remains uncertain. In recent years, noninvasive blood biomarkers have garnered increasing attention in predicting Alzheimer's disease development. Within the general population, neurofilament light chain levels have been used to prognosticate changes in cognitive function alongside the amyloid beta 1-42/1-40 (Aβ1-42/1-40) ratio. Nevertheless, this has not been studied in patients with chronic kidney disease, particularly those undergoing hemodialysis.

Methods

This exploratory cross-sectional study investigated the association of the serum Aβ1-42/1-40 ratio and neurofilament light chain levels with cognitive function, assessed using the Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE), in patients undergoing hemodialysis.

Results

We included 384 patients with a median age of 74 (interquartile range [IQR]: 70–80) years. The median (IQR) MoCA and MMSE scores were 25 (22–26) and 28 (26–29), respectively. The median (IQR) Aβ1-42/1-40 ratio and neurofilament light chain level were 0.04 (0.03–0.06) and 196.2 pg/mL (146.5–262.2), respectively. The multivariate linear regression analysis indicated a weak negative association between the log-transformed neurofilament light chain levels and cognitive function, after adjusting for confounding factors including age (β coefficient [95 % confidence interval], -0.98 [-1.81, -0.15]; P = 0.021 for MoCA and -0.66 [-1.32, -0.01]; P = 0.046 for MMSE). However, the Aβ1-42/1-40 ratio was not associated with cognitive function.

Conclusions

Our exploratory analysis identified a weak negative association between serum neurofilament light chain levels and cognitive function in patients undergoing hemodialysis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal DialysisNeurofilament ProteinsCognitive DysfunctionKidney Failure, ChronicHumansCross-Sectional StudiesFemaleMaleAmyloid beta-PeptidesAgedBiomarkersPeptide FragmentsAged, 80 and overMiddle AgedMental Status and Dementia TestsCognition

Stichwörter der Autor:innen

dementiahemodialysismineral metabolism

Substanzen

Amyloid beta-PeptidesNeurofilament ProteinsBiomarkersneurofilament protein LPeptide Fragmentsamyloid beta-protein (1-42)amyloid beta-protein (1-40)

Autor:innen und Institutionen

  • Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
  • Division of Molecular Epidemiology, The Jikei University School of Medicine, Tokyo, Japan.
  • Department of Psychiatry, The Jikei University School of Medicine, Tokyo, Japan.
  • Human Health Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan.

ORCID-Profile: Kazuhiko Kato, Akio Nakashima, Shunichiro Shinagawa, Mitsuyoshi Urashima, Takashi Yokoo

Förderung

  • JSPS KAKENHI
  • The Grant for Pathophysiological Research Conference in Chronic Kidney Disease from The Kidney Foundation, Japan

Zitieren

APA

Kato, K., Nakashima, A., Shinagawa, S., Kobayashi, A., Ohkido, I., Urashima, M., & Yokoo, T. (2026). Neurofilament Light Chain and Cognitive Dysfunction in Patients Undergoing Hemodialysis. Kidney360. https://doi.org/10.34067/kid.0000001162

Vancouver

Kato K, Nakashima A, Shinagawa S, Kobayashi A, Ohkido I, Urashima M, et al. Neurofilament Light Chain and Cognitive Dysfunction in Patients Undergoing Hemodialysis. Kidney360. 2026. doi:10.34067/kid.0000001162

BibTeX
@article{Kato2026,
  author = {Kato, Kazuhiko and Nakashima, Akio and Shinagawa, Shunichiro and Kobayashi, Arisa and Ohkido, Ichiro and Urashima, Mitsuyoshi and Yokoo, Takashi},
  title = {Neurofilament Light Chain and Cognitive Dysfunction in Patients Undergoing Hemodialysis},
  journal = {Kidney360},
  year = {2026},
  doi = {10.34067/kid.0000001162}
}
Kostenlos starten →